Exact Mass: 437.1838
Exact Mass Matches: 437.1838
Found 191 metabolites which its exact mass value is equals to given mass value 437.1838
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Fluphenazine
Fluphenazine is only found in individuals that have used or taken this drug. It is a phenothiazine used in the treatment of psychoses. Its properties and uses are generally similar to those of chlorpromazine. [PubChem]Fluphenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Alobresib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
(S)-2-[(S)-2-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-succinic acid
(2S)-2-[[(2S)-2-[[(2S)-2-Amino-3-methylbutanoyl]amino]propanoyl]-phenylmethoxycarbonylamino]butanedioic acid
(E)-3-(methylsulfonyl)-propenoic acid (2E,6E)-3-hydroxy-4-(8-hydroxy-3,7-dimethyl-2,6-octadienyloxy)-phenethyl amide|sakerinol A
(E)-3-(methylsulfonyl)-propenoic acid (2E,6E)-2-[4-(8-hydroxy-3,7-dimethyl-2,6-octadienyloxy)-phenyl]-2-hydroxyethyl amide|beta-hydroxygerambullol|??-Hydroxygerambullol
WWL70
WWL70 is a selective alpha/beta hydrolase domain 6 (ABHD6) inhibitor with an IC50 of 70 nM.
Fluphenazine (oxide)
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Ala Ala Asn Tyr
Ala Ala Tyr Asn
Ala Phe Asn Ser
Ala Phe Ser Asn
Ala Gly Gln Tyr
Ala Gly Tyr Gln
Ala Asn Ala Tyr
Ala Asn Phe Ser
Ala Asn Ser Phe
Ala Asn Tyr Ala
Ala Gln Gly Tyr
Ala Gln Tyr Gly
Ala Ser Phe Asn
Ala Ser Asn Phe
Ala Tyr Ala Asn
Ala Tyr Gly Gln
Ala Tyr Asn Ala
Ala Tyr Gln Gly
Cys Gly Lys Met
Cys Gly Met Lys
Cys Lys Gly Met
Cys Lys Met Gly
Cys Met Gly Lys
Cys Met Lys Gly
Phe Ala Asn Ser
Phe Ala Ser Asn
Phe Gly Asn Thr
Phe Gly Gln Ser
Phe Gly Ser Gln
Phe Gly Thr Asn
Phe Asn Ala Ser
Phe Asn Gly Thr
Phe Asn Ser Ala
Phe Asn Thr Gly
Phe Gln Gly Ser
Phe Gln Ser Gly
Phe Ser Ala Asn
Phe Ser Gly Gln
Phe Ser Asn Ala
Phe Ser Gln Gly
Phe Thr Gly Asn
Phe Thr Asn Gly
Gly Ala Gln Tyr
Gly Ala Tyr Gln
Gly Cys Lys Met
Gly Cys Met Lys
Gly Phe Asn Thr
Gly Phe Gln Ser
Gly Phe Ser Gln
Gly Phe Thr Asn
Gly Lys Cys Met
Gly Lys Met Cys
Gly Met Cys Lys
Gly Met Lys Cys
Gly Asn Phe Thr
Gly Asn Thr Phe
Gly Gln Ala Tyr
Gly Gln Phe Ser
Gly Gln Ser Phe
Gly Gln Tyr Ala
Gly Ser Phe Gln
Gly Ser Gln Phe
Gly Thr Phe Asn
Gly Thr Asn Phe
Gly Tyr Ala Gln
Gly Tyr Gln Ala
Lys Cys Gly Met
Lys Cys Met Gly
Lys Gly Cys Met
Lys Gly Met Cys
Lys Met Cys Gly
Lys Met Gly Cys
Met Cys Gly Lys
Met Cys Lys Gly
Met Gly Cys Lys
Met Gly Lys Cys
Met Lys Cys Gly
Met Lys Gly Cys
Asn Ala Ala Tyr
Asn Ala Phe Ser
Asn Ala Ser Phe
Asn Ala Tyr Ala
Asn Phe Ala Ser
Asn Phe Gly Thr
Asn Phe Ser Ala
Asn Phe Thr Gly
Asn Gly Phe Thr
Asn Gly Thr Phe
Asn Ser Ala Phe
Asn Ser Phe Ala
Asn Thr Phe Gly
Asn Thr Gly Phe
Asn Tyr Ala Ala
Gln Ala Gly Tyr
Gln Ala Tyr Gly
Gln Phe Gly Ser
Gln Phe Ser Gly
Gln Gly Ala Tyr
Gln Gly Phe Ser
Gln Gly Ser Phe
Gln Gly Tyr Ala
Gln Ser Phe Gly
Gln Ser Gly Phe
Gln Tyr Ala Gly
Gln Tyr Gly Ala
Ser Ala Phe Asn
Ser Ala Asn Phe
Ser Phe Ala Asn
Ser Phe Gly Gln
Ser Phe Asn Ala
Ser Phe Gln Gly
Ser Gly Phe Gln
Ser Gly Gln Phe
Ser Asn Ala Phe
Ser Asn Phe Ala
Ser Gln Phe Gly
Ser Gln Gly Phe
Thr Phe Gly Asn
Thr Phe Asn Gly
Thr Gly Phe Asn
Thr Gly Asn Phe
Thr Asn Phe Gly
Thr Asn Gly Phe
Tyr Ala Ala Asn
Tyr Ala Gly Gln
Tyr Ala Asn Ala
Tyr Ala Gln Gly
Tyr Gly Ala Gln
Tyr Gly Gln Ala
Tyr Asn Ala Ala
Tyr Gln Ala Gly
Tyr Gln Gly Ala
Oxolamine citrate
D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents
(6-Chloro-1-(2-(dimethylamino)ethyl)indol-3-yl)-spiro(1H-isobenzofuran-3,4-piperidine)-1-yl-methanone
N-[1,4-dioxo-3-(4-phenyl-1-piperazinyl)-2-naphthalenyl]benzamide
Meropenem Hydrate
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
(S)-2-[(S)-2-((S)-2-Benzyloxycarbonylamino-3-methyl-butyrylamino)-propionylamino]-succinic acid
(2S)-2-[[(2S)-2-[[(2S)-2-Amino-3-methylbutanoyl]amino]propanoyl]-phenylmethoxycarbonylamino]butanedioic acid
(4-Tert-butylphenyl)-[2-(4-fluorophenyl)-8-methyl-3-sulfanylidene-1,4,8-triazaspiro[4.5]dec-1-en-4-yl]methanone
3-(2,3-dimethoxyphenyl)-1-(9-methyl-2-phenyl-9H-imidazo[1,2-a]benzimidazol-3-yl)prop-2-en-1-one
(6S,7R,8S)-N-(2-fluorophenyl)-8-(hydroxymethyl)-7-[4-(3-methoxyprop-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7R,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-7-[4-(3-methoxyprop-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8S)-N-(2-fluorophenyl)-8-(hydroxymethyl)-7-[4-(3-methoxyprop-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7S,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-7-[4-(3-methoxyprop-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-7-[4-(3-methoxyprop-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8S)-N-(2-fluorophenyl)-8-(hydroxymethyl)-7-[4-(3-methoxyprop-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7S,8S)-N-(2-fluorophenyl)-8-(hydroxymethyl)-7-[4-(3-methoxyprop-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8R)-N-(2-fluorophenyl)-8-(hydroxymethyl)-7-[4-(3-methoxyprop-1-ynyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(2R,4S)-2-[(1R)-1-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-2-(butylamino)-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylate
(2S)-2-(2-ethoxyanilino)-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]propanamide
n-(2-hydroxy-2-{4-[(8-hydroxy-3,7-dimethylocta-2,6-dien-1-yl)oxy]phenyl}ethyl)-3-methanesulfonylprop-2-enimidic acid
β-hydroxygerambullol
{"Ingredient_id": "HBIN018158","Ingredient_name": "\u03b2-hydroxygerambullol","Alias": "NA","Ingredient_formula": "C22H31NO6S","Ingredient_Smile": "CC(=CCOC1=CC=C(C=C1)C(CNC(=O)C=CS(=O)(=O)C)O)CCC=C(C)CO","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10139","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}